Aurinia Pharmaceuticals Inc (AUPH)
8.88
+0.11
(+1.25%)
USD |
NASDAQ |
Nov 22, 16:00
8.88
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Total Liabilities (Quarterly): 161.36M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 161.36M |
| June 30, 2024 | 158.91M |
| March 31, 2024 | 157.16M |
| December 31, 2023 | 170.11M |
| September 30, 2023 | 163.14M |
| June 30, 2023 | 156.61M |
| March 31, 2023 | 61.35M |
| December 31, 2022 | 65.42M |
| September 30, 2022 | 64.87M |
| June 30, 2022 | 58.38M |
| March 31, 2022 | 58.78M |
| December 31, 2021 | 64.28M |
| September 30, 2021 | 61.89M |
| June 30, 2021 | 54.01M |
| March 31, 2021 | 46.85M |
| December 31, 2020 | 55.91M |
| September 30, 2020 | 62.91M |
| June 30, 2020 | 56.24M |
| March 31, 2020 | 51.56M |
| December 31, 2019 | 25.70M |
| September 30, 2019 | 27.10M |
| June 30, 2019 | 25.37M |
| March 31, 2019 | 25.16M |
| December 31, 2018 | 33.29M |
| September 30, 2018 | 32.35M |
| Date | Value |
|---|---|
| June 30, 2018 | 25.68M |
| March 31, 2018 | 23.96M |
| December 31, 2017 | 24.10M |
| September 30, 2017 | 32.19M |
| June 30, 2017 | 29.34M |
| March 31, 2017 | 47.03M |
| December 31, 2016 | 21.05M |
| September 30, 2016 | 13.15M |
| June 30, 2016 | 10.65M |
| March 31, 2016 | 11.72M |
| December 31, 2015 | 13.60M |
| September 30, 2015 | 15.40M |
| June 30, 2015 | 16.37M |
| March 31, 2015 | 20.45M |
| December 31, 2014 | 18.51M |
| September 30, 2014 | 7.079M |
| June 30, 2014 | 9.106M |
| March 31, 2014 | 8.655M |
| December 31, 2013 | 9.854M |
| September 30, 2013 | 11.10M |
| June 30, 2013 | 6.768M |
| March 31, 2013 | 6.565M |
| December 31, 2012 | 6.276M |
| September 30, 2012 | 5.532M |
| June 30, 2012 | 5.232M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
25.70M
Minimum
Dec 2019
170.11M
Maximum
Dec 2023
87.77M
Average
62.40M
Median
Total Liabilities (Quarterly) Benchmarks
| Edesa Biotech Inc | 2.361M |
| Lexaria Bioscience Corp | 0.2714M |
| Xenon Pharmaceuticals Inc | 38.09M |
| ESSA Pharma Inc | 3.805M |
| ImmunoPrecise Antibodies Ltd | 19.09M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 549.36M |
| Shareholders Equity (Quarterly) | 388.00M |
| Current Ratio | 5.603 |